Guadeloupe

Reimbursed Care Access

Guadeloupe is an overseas department of France, so French national drug and medicines law applies. Most classical psychedelics (psilocybin, MDMA, DMT, mescaline, ibogaine, 5‑MeO‑DMT, 2C‑X, ayahuasca preparations) are listed as controlled substances under the French narcotics schedules and have no authorised routine medical use outside approved clinical research; esketamine (SPRAVATO®) is the single psychedelic‑class medication with an EU/France hospital‑restricted marketing authorisation and conditional reimbursement under strict criteria. Off‑label racemic ketamine is used clinically (e.g., IV infusion) in private practice for depression in specialized centres but is not a broadly reimbursed, standard social‑security benefit for that indication.